The USA Patient Network

Read why President Trump's plan to streamline the FDA approval process will make patients less safe and will cause their health to suffe

President Diana Zuckerman is cited in an article that discusses the effectiveness of recently approved oncology drugs that seem to offer lit

In a meeting with top pharmaceutical executives, President Trump offers no specific policies but emphasizes the need for lowering drug price

President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash reg

As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he

A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event r

The evidence supporting Exondys 51, an FDA approved drug meant to treat Duchenne muscular dystrophy, is too thin for a drug that costs $300,

The Food and Drug Administration's approval process is confusing, complicated and intertwined with lobbyists and top drug company execut

Doctors often prescribe drugs "off label", meaning for purposes it wasn't approved for by the FDA. Most don't tell their p

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies sho

At an August 15, 2016 public forum convened by the Food and Drug Administration, some panelists have financial ties not disclosed to the pub

Pharma says this bill will create cures for diseases but Sen. Elizabeth Warren blasts 21st Century Cures Act, saying she knows the differenc

Will Trump Administration help Pharma to lower FDA standards or will they care about patient safety? We say “who knows?” Read the article he